Use of liposomized tetracycline in elimination of Wolbachia endobacterium of human lymphatic filariid Brugia malayi in a rodent model

Journal of Drug Targeting

Volumn 13, Issue 6, 2005, Pages 375-381

  Bajpai, Preeti ^a   Vedi, Satish ^a   Owais, Mohammad ^b   Sharma, Sharad K ^b   Saxena, Prabh N ^c   Misra Bhattacharya, Shailja ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

^b ALIGARH MUSLIM UNIVERSITY   (India)

^c Institute of Basic Sciences Agra   (India)

Author keywords

Antifilarial efficacy; Brugia malayi; Lymphatic filaria; Tetracycline; Wolbachia

Indexed keywords

ANTIBIOTIC AGENT; GENOMIC DNA; LIPOSOME; PHOSPHATE BUFFERED SALINE; TETRACYCLINE;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRUGIA MALAYI; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; FILARIASIS; IN VITRO STUDY; LONG TERM CARE; LYMPHATIC SYSTEM INFECTION; MASTOMYS; MICROFILARIASIS; NONHUMAN; PRIORITY JOURNAL; RAT; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; STUDENT T TEST; WOLBACHIA;

ADMINISTRATION, ORAL; ANIMALS; ANTI-BACTERIAL AGENTS; BRUGIA MALAYI; DISEASE MODELS, ANIMAL; ELEPHANTIASIS, FILARIAL; FEMALE; HUMANS; LIPOSOMES; RATS; TETRACYCLINE; WOLBACHIA;

EID: 28044439891     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.1080/10611860500285439     Document Type: Article

References (42)

1. Adams LB, Sinha I, Franzblau SG, Krahenbuhl JL, Mehta RT. 1999. Effective treatment of acute and chronic murine tuberculosis with liposome encapsulated clofazimine. Anti-microb Agents Chemother 43:1638-1643.
2. Alving CR, Steck EA, Chapman WL. 1978. Therapy of leishmaniasis: Superior efficacy of liposome-encapsulated drugs. Proc Natl Acad Sci USA 75:2959-2963.
3. Ash LR, Relay JM. 1970. Development of Brugia malayi in the jird, Meriones unguiculatus, with notes on infection in other rodents. J Parasitol 56:962-968.
4. Bandi C, Damiani G, Magrassi L, Grigolo A, Fani R, Sacchi L. 1994. Flavobacteria as intracellular symbionts in cockroaches. Proc R Soc Lond B 257:43-48.
5. Bandi C, Anderson TJC, Genchi C, Blaxter ML. 1998. Phylogeny of Wolbachia in filarial nematodes. Proc R Soc Lond B 265:2407-2413.
6. Bandi C, Trees AJ, Brattig NW. 2001. Wolbachia in filarial nematodes: Evolutionary aspects and implications for the pathogenesis and treatment of filarial diseases. Vet Parasitol 98:215-238.
7. Berman JD, Ksionski G, Chapman WL, Waits VB, Hanson WL. 1992. Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis. Antimicrob Agents Chemother 36:1978-1980.
8. Bermudez LE, Yan-Young AD, Lin JP, Cogger J, Young LS. 1990. Treatment of disseminated Mycobacterium avium complex infection of mice with liposome-encapsulated aminoglycosides. J Infect Dis 161:1262-1268.
9. Bosshardt SC, McCall JW, Coleman SH, Jones KL, Petit TA, Klei TL. 1993. Prophylactic activity of tetracycline against Brugia pahangi infection in Jirds (Meriones uniguiculatus). J Parasitol 79:775-777.
10. Buttner DW, Wanji S, Bazzocchi C, Bain O, Fischer P. 2003. Obligatory symbiotic Wolbachia endobacteria are absent from Loa loa. Filaria J 2: 10.
11. Casiraghi M, McCall JW, Simoncini L. 2002. Tetracycline treatment and sex ratio distortion: A role for Wolbachia in the moulting of filarial nematodes? Int J Parasitol 32:1457-1468.
12. Chirgwin SR, Porthouse KH, Nowling JM, Klei TR. 2002. The filarial endosymbiont Wolbachia sp. is absent from Setaria equina. J Parasitol 88:1248-1250.
13. Chirgwin SR, Coleman SU, Porthouse KH, Nowling JM, Punkosdy GA, Klei TR. 2003. Removal of Wolbachia from Brugia pahangi is closely linked to worm death and fecundity but does not result in altered lymphatic lesion formation in Mongolian gerbils (Meriones unguiculatus). Infect Immun 71:6986-6994.
14. Chopra I, Hawkey PM, Hinton M. 1992. Tetracyclines, molecular and clinical aspects. J Antimicrob Chemother 29:245-277.
15. Clark JM, Whitney RR, Olsen SJ. 1991. Amphotericin B lipid complex therapy of experimental fungal infections in mice. Antimicrob Agents Chemother 35:615-621.
16. Deol P, Khuller GK. 1997. Lung specific stealth liposomes: Stability, biodistribution and toxicity of liposomal antitubercular drugs in mice. Biochim Biophys Acta 1334:161-172.
17. Dutt M, Khuller GK. 2001. Liposomes and PLG microparticles as sustained release antitubercular drug carriers - an in vitro-in vivo study. Int J Antimicrob Agents 18:245-252.
18. Gondal JA, Swartz RP, Rahman A. 1989. Therapeutic evaluation of free liposome-encapsulated amphotericin B in the treatment of systemic candidiasis in mice. Antimicrob Agents Chemother 33:1544-1548.
19. Hoerauf A, Adjei O, Büttner DW. 2002. Antibiotics for die treatment of onchocerciasis and other filarial infections. Curr Opin Investig Drugs 3:533-537.
20. Hoerauf A, Volkmann L, Hamelmann C. 2000. Endosymbiotic bacteria in worms as targets for a novel chemotherapy in filariasis. Lancet 355:1242-1243.
21. Irma AJM, Woudenberg B, ten Kate MT, Stearne-Cullen LET, Woodle MC. 1995. Efficacy of Gentamicin or Ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella Pneumoniae-infected lung tissue. J Infect Dis 171:938-947.
22. Karlowsky JA, Zhanel GG. 1992. Concepts on the use of liposomal antimicrobial agents: Applications for aminoglycosides. Clin Infect Dis 15:654-667.
23. Kende M, Alving CR, Rill WL, Swartz GM, Canonico PG. 1985. Enhanced efficacy of iposome-encapsulated ribavirin against Rift Valley fever virus infection in mice. Antimicrob Agents Chemother 27:903-907.
24. Langworthy NG, Renz A, Mackenstedt U. 2000. Macrofilaricidal activity of tetracycline against the filarial nematode Onchoceca ochengi: Elimination of Wolbachia precedes worm death and suggests a dependent relationship. Proc R Soc Lond B 267:1063-1069.
25. Lin DS, Coleman SU, Rao UP, Klei TR. 1995. Absence of protective resistance to homologous challenge infections in jirds with chronic amicrofilaraemic infections of Brugia pahangi. J Parasitol 81:643-646.
26. Mc Call JW, Jun JJ, Bandi C. 1999. Wolbachia and the antifilarial properties of tetracycline. An untold story. Ital J Zool 66:7-10.
27. Melrose WD. 2003. Chemotherapy for lymphatic filariasis: Progress but not perfection. Expert Rev Anti-Infect Ther 4:571-577.
28. Misra S, Chatterjee RK, Sen AB. 1984. The response of Litomosoides carinii to antifilarial agents in cotton rat (Sigmodon hispidus) and multimammate rat (Mastomys natalensis). Ind J Med Res 79:749-754.
29. Misra-Bhattacharya S, Katiyar D, Bajpai P, Tripathi RP, Saxena JK. 2004. 4-Methyl-7- (tetradecanoyl)-2H-1-benzopyran-2-one: A novel DNA topoisomerase II inhibitor with adulticidal and embryo static activity against sub periodic Brugia malayi. Parasitol Res 92(3):177-182.
30. Owais M, Krishankumar B, Jain RK, Bachhawat BK, Gupta CM. 1993. Tuftsin bearing liposomes as drug vehicles in the treatment of experimental aspergillosis. FEBS Lett 326:56-58.
31. Owais M, Misra-Bhattacharya S, Haq W, Gupta CM. 2003. Immunomodulator tuftsin augments antifilarial activity of diethylcarbamazine against experimental brugian filariasis. J Drug Target 11:247-251.
32. Porter CJH. 1997. Drug delivery to the lymphatic system. Crit Rev Ther Drug Carrier Syst 14:333-393.
33. Sangaré L, Morisset R, Gaboury L, Ravaoarinoro M. 2001. Effects of cationic liposome-encapsulated doxycycline on experimental Chlamydia trachomatis genital infection in mice. J Antimicrob Chemother 47:323-331.
34. Sangaré L, Morisset R, Omri A, Ravaorinoro M. 1998. Incorporation rates, stabilities, cytotoxicities and release of liposomal tetracycline and doxycycline in human serum. J Antimicrob Chemother 42:831-834.
35. Sangaré K, Morisset R, Ravaoarinoro M. 1999. In-vitro anti-chlamydial activities of free and liposomal tetracycline and doxycycline. J Med Microb 48:689-693.
36. Singh U, Misra S, Murthy PK, Katiyar JC, Agarwal A, Sircar AR. 1997. Immunoreactive molecules of Brugia malayi and their diagnostic potential. Serodiag Immunother Infect Dis 8:207-212.
37. Singleton WS, Gray MS, Brown ML, White JL. 1965. Preparation of egg yolk lecithin. J Am Oil Chem Soc 42:53-56.
38. Taylor MJ, Bilo K, Cross HF, Archer JP, Underwood AP. 1999b. 16S rDNA phylogeny and ultra structural characterization of Wolbachia intracellular bacteria of filarial nematodes, Brugia malayi, Brugia pahangi and Wuchereria bancrofti. Exp Parasitol 91:356-361.
39. Taylor MJ, Bandi C, Hoerauf AM, Lazdins J. 2000a. Wolbachia bacteria of filarial nematodes: A target for control? Parasitol Today 16:179-180.
40. Taylor MJ, Cross HF, Bilo K. 2000b. Inflammatory responses induced by filarial nematodes Brugia malayi are mediated by lipopolysaccharide like activity from endosymbiotic Wolbachia bacteria. J Exp Med 191:1429-1436.
41. Taylor MJ, Hoerauf AM. 1999a. Wolbachia bacteria of filarial nematodes. Parasitol Today 15:437-442.
42. Tyagi K, Misra-Bhattacharya S. 2003. Brugia malayi in Mastomys coucha: Tetracycline a tool for transmission blocking. Curr Sci 85:588-589.